Clinical Trial Update: An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial update reporting efficacy and safety results for the initiation and maintenance treatment of anemia in chronic kidney disease using epoetin alfa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Anemia of Chronic Kidney Disease

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2010-02-08